This review outlines clinical management strategies for coronary heart disease in patients with chronic kidney disease and end-stage renal disease, emphasizing the lack of dedicated clinical trial data in this high-risk population.
Answers are grounded in this paper and cite their sources.
Evidence gaps leave CHD management uncertain in CKD/ESRD; dedicated RCTs needed before practice change.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Charles A. Herzog (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: